Sze Wan Shan

1.5k citations
41 papers · 1.2k indexed · h-index 18

Sze Wan Shan

39 papers receiving 1.2k citations

Peers

Sze Wan Shan
Comparison fields: 5 of 94
  • Cancer Research 652
  • Ophthalmology 133
  • Molecular Biology 872
  • Immunology and Allergy 32
  • Cell Biology 85
Replace Vito D’Agostino with:
Vito D’Agostino Italy
Núria Colomé Spain
Dawid G. Nowak United States
Melissa V. Gammons United Kingdom
Amy E. Birsner United States
Christine Neuhaus Germany
Toshifumi Yae Japan
Pegah Rouhi Sweden
Nives Pećina‐Šlaus Croatia
Dantong Sun China
Sze Wan Shan relative to Vito D’Agostino Italy Vito D’Agostino's profile →
Citations per field
00.5×1.7×
Vito D’Agostino · 1×
Citations per year

Countries citing papers authored by Sze Wan Shan

Since Specialization
Citations

This map shows the geographic impact of Sze Wan Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sze Wan Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sze Wan Shan more than expected).

Fields of papers citing papers by Sze Wan Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sze Wan Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sze Wan Shan. The network helps show where Sze Wan Shan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sze Wan Shan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sze Wan Shan Line = papers co-authored together Sze Wan Shan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20231
4 20234
5 20223
6 20223
7 202029
8 20201
9
The effects of a Rho-associated protein kinase (ROCK) inhibitor (Y39983) on human trabecular meshwork cells – a morphological and proteomic study
20193
10 201710
11 20155
12 201314
13 2013124
14 201244
15 201131
16
Characterization of Cl- Transporter and Channels in Lens-Induced Myopic Eyes
20101
17 2010262
18 200624
19 200517
20 200519

About Sze Wan Shan

Sze Wan Shan is a scholar working on Ophthalmology, Cancer Research and Aging, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Glaucoma and retinal disorders (9 papers), MicroRNA in disease regulation (6 papers), Ophthalmology and Visual Impairment Studies (6 papers), Corneal surgery and disorders (6 papers), Connexins and lens biology (6 papers), Retinal Development and Disorders (4 papers) and Intraocular Surgery and Lenses (3 papers). The work is most often cited by research in Cancer Research (652 citations), Ophthalmology (133 citations) and Molecular Biology (872 citations). Sze Wan Shan has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Zhaoqun Deng, Burton B. Yang, William W. Du, Tatiana Shatseva, Albert Yee, Jim W. Xuan, Chun Peng, Ling Fang, Chi Ho To and Lee Cyn Ang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026